163.31
0.43%
0.70
Dopo l'orario di chiusura:
163.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZTS Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$162.61
Aprire:
$162.24
Volume 24 ore:
2.01M
Relative Volume:
0.92
Capitalizzazione di mercato:
$73.68B
Reddito:
$9.15B
Utile/perdita netta:
$2.43B
Rapporto P/E:
30.70
EPS:
5.32
Flusso di cassa netto:
$2.31B
1 W Prestazione:
-0.78%
1M Prestazione:
-7.70%
6M Prestazione:
-7.00%
1 anno Prestazione:
-15.35%
Zoetis Inc Stock (ZTS) Company Profile
Nome
Zoetis Inc
Settore
Telefono
973-822-7000
Indirizzo
10 SYLVAN WAY, PARSIPPANY, NJ
Confronta ZTS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
163.31 | 73.68B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.46 | 42.77B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.26 | 42.04B | 30.27B | 1.93B | 3.45B | 0.6044 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.24 | 24.07B | 16.77B | -959.00M | 1.37B | -0.85 |
VTRS
Viatris Inc
|
12.28 | 14.66B | 15.05B | -883.30M | 1.89B | -0.74 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-02 | Iniziato | Leerink Partners | Outperform |
2024-07-25 | Iniziato | BTIG Research | Buy |
2024-01-12 | Reiterato | Stifel | Buy |
2023-12-19 | Ripresa | Jefferies | Buy |
2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
2023-09-06 | Iniziato | HSBC Securities | Buy |
2022-07-12 | Iniziato | Piper Sandler | Overweight |
2021-11-18 | Iniziato | Morgan Stanley | Overweight |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2021-07-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
2021-03-08 | Aggiornamento | BofA Securities | Neutral → Buy |
2021-03-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-09-21 | Iniziato | Atlantic Equities | Overweight |
2020-08-14 | Aggiornamento | Edward Jones | Hold → Buy |
2020-08-12 | Downgrade | Gabelli & Co | Buy → Hold |
2020-05-27 | Iniziato | Jefferies | Buy |
2020-01-10 | Iniziato | Raymond James | Mkt Perform |
2019-09-09 | Iniziato | Goldman | Buy |
2019-07-01 | Downgrade | BofA/Merrill | Buy → Neutral |
2019-06-11 | Iniziato | Barclays | Overweight |
2019-05-23 | Iniziato | Guggenheim | Buy |
2019-05-03 | Downgrade | Gabelli & Co | Buy → Hold |
2019-03-20 | Iniziato | SunTrust | Hold |
2019-03-04 | Aggiornamento | Stifel | Hold → Buy |
2019-01-23 | Iniziato | UBS | Neutral |
2018-10-15 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-08-22 | Downgrade | Stifel | Buy → Hold |
2018-08-03 | Reiterato | Stifel | Buy |
2018-04-19 | Reiterato | Citigroup | Buy |
2018-03-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2018-02-16 | Reiterato | Stifel | Buy |
2018-01-04 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Zoetis Inc Borsa (ZTS) Ultime notizie
Zoetis Inc. stock rises Friday, still underperforms market - MarketWatch
GAMMA Investing LLC Acquires 3,165 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
AHP Launches Sixth Equine Industry Survey, Sponsored by Zoetis - TheHorse.com
Zoetis to Acquire Animal Health Assets of Abbott - Farm Progress
GeneDx appoints former Zoetis general counsel as legal chief - | Governance Intelligence
Zoetis (ZTS) is a Top-Ranked Growth Stock: Should You Buy? - MSN
Is Zoetis Inc. (ZTS) the Best Pharma Dividend Stock to Buy In 2024? - Insider Monkey
13 Best Pharma Dividend Stocks To Buy In 2024 - Insider Monkey
Pet Medication Market Projected To Witness Substantial Growth, 2024-2031: Zoetis, Merck, Elanco, Bayer, - EIN News
JPMorgan Chase & Co. Grows Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
ZTS: Is Zoetis a Smart Investment in the Pharmaceuticals Sector? - StockNews.com
ZTS: 3 Healthcare Innovators with Analyst-Endorsed Upside - StockNews.com
Zoetis Inc. (ZTS): A Bull Case Theory - MSN
The Wall Street Journal Vs. Zoetis (ZTS) - Seeking Alpha
Zoetis Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zoetis Inc. (NYSE:ZTS) Shares Sold by M&T Bank Corp - MarketBeat
Here's Why Zoetis (ZTS) Gained But Lagged the Market Today - MSN
Livestock Drug Market to See Stunning Growth with Zoetis, Elanco, Bayer Animal Health - openPR
Zoetis Inc. (NYSE:ZTS) Receives $215.22 Consensus PT from Brokerages - MarketBeat
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zoetis is Now Oversold (ZTS) - Nasdaq
📈 Is Zoetis a good stock to buy? - substack.com
Earnings growth of 2.9% over 3 years hasn't been enough to translate into positive returns for Zoetis (NYSE:ZTS) shareholders - Simply Wall St
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income - The Motley Fool
Zoetis dips as FDA cites adverse events linked to canine pain therapy Librela - MSN
Zoetis donates $100,000 to support vet mental health - Vet Practice magazine
Elliott Wave Pattern Puts Zoetis Bulls On Alert - EWM Interactive
Zoetis stock dips after FDA notice on Librela (ZTS:NYSE) - Seeking Alpha
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet? - Yahoo Finance
Zoetis Issues Vaccine Reminder for Pregnant Broodmares in Third Trimester - EQUUS Magazine
Here's Why Zoetis (ZTS) is a Strong Growth Stock - Yahoo Finance
American Trust Sells 4,044 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Wilmington Savings Fund Society FSB Increases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
World Investment Advisors LLC Has $6.69 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stake Lessened by Sanctuary Advisors LLC - MarketBeat
Podcast: Harness Culture to Drive Value with Zoetis’ Supply Chain EVP - Gartner
Zoetis Boosts Dividend by 16% for 2025 - TipRanks
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase - Business Wire
Stock Yards Bank & Trust Co. Lowers Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Toronto Dominion Bank Increases Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Pain Management Market Is Booming Worldwide - openPR
Why Zoetis Inc. (NYSE:ZTS) Looks Like A Quality Company - Yahoo Finance
TCW Group Inc. Has $123.40 Million Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Geode Capital Management LLC Purchases 185,364 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Companion Animal Diagnostics Market 2024 to Witness Huge Growth - openPR
Zoetis CFO Says Resiliency In Animal Health Enables Innovation - Forbes
Zoetis initiated with a Neutral at UBS - Yahoo Finance
Zoetis : Announces Global Launch of Vetscan OptiCell™ at VMX 2025 - Marketscreener.com
Zoetis to Debut AI-Powered Haematology Technology at London Vet Show - The Eastern Progress Online
Zoetis (NYSE:ZTS) Coverage Initiated at UBS Group - MarketBeat
Tylosin Market Expected to Reach US$ 605 million by 2031 | Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical. - openPR
Zoetis Inc Azioni (ZTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):